MRT-8102

· Monte Rosa Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRT-8102, covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP [Phase 1]

See pricing